##### Table of Contents

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549



---

(Amendment No. 1)

FORM 10-QSB/A



---



|x | Quarterly report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
|- | ----------------------------------------------------------------------------------------

For the Quarterly Period Ended June 30, 2007



| ̈ | Transition report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
|- | -----------------------------------------------------------------------------------------

Commission File No. 0-20948



---

AUTOIMMUNE INC.

(Exact Name of
Small Business Issuer as Specified in its Charter)



---



|                         |  |                                     
|------------------------ |  | ------------------------------------
|Delaware                 |  | 13-348-9062                         
|(State of Incorporation) |  | (I.R.S. Employer Identification No.)

1199 Madia Street, Pasadena, CA 91103

(Address of Principal Executive Offices)

(626) 792-1235

(Issuers Telephone No., including Area Code)



---

Check whether the issuer: (1) filed all
reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days.    Yes  x    No ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act.):    Yes  x    No ̈

Number of shares outstanding of the registrants Common Stock as of August 7, 2007:



|                             |  |                              
|---------------------------- |  | -----------------------------
|Common Stock, par value $.01 |  | 16,979,623 shares outstanding

Indicate by check mark whether Transitional Small Business Disclosure Format
:    Yes ̈No  x



---



---

##### Table of Contents

Explanatory Note

We are filing this Amendment No. 1 to our Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007, solely to include information in Item 4 of Part II regarding matters submitted to a vote of
security holders during the period covered by the original report on Form 10-QSB. No other information included in the original report on Form 10-QSB is amended by this Form 10-QSB/A.

AUTOIMMUNE INC.

QUARTER ENDED JUNE 30, 2007

TABLE OF CONTENTS



|                                                             |  |            
|------------------------------------------------------------ |  | -----------
|                                                             |  | Page Number
|PART II - OTHER INFORMATION                                  |  |            
|                                                             | 
|Item 4  Submission of Matters to a Vote of Security Holders |  | 3          
|                                                             | 
|Item 6(a) - Exhibits                                         |  | 3          
|                                                             | 
|Signatures                                                   |  | 4          



2



---

##### Table of Contents

AUTOIMMUNE INC.

PART IIOTHER INFORMATION

ITEM 4  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

(a) The Annual Meeting of
Stockholders was held on May 17, 2007.

(c) The following directors were elected to serve until the next Annual Meeting or until their
successors are elected and qualified, by the following votes:



|                  |  |                     |  |                          |  |        
|----------------- |  | ------------------- |  | ------------------------ |  | -------
|Name              |  | Number of Votes For |  | Number of Votes Withheld |  | Abstain
|Robert C. Bishop  |  | 14,155,242          |  | 991,010                  |  | 0      
|Hugh A. DAndrade |  | 14,936,378          |  | 209,874                  |  | 0      
|Allan R. Ferguson |  | 14,936,628          |  | 209,624                  |  | 0      
|R. John Fletcher  |  | 14,117,842          |  | 1,028,410                |  | 0      

ITEM 6.    EXHIBITS AND REPORTS ON FORM 8-K

Exhibits (numbered in accordance with Item 601 of
Regulation S-B)



|               |  |                                                                                                                      
|-------------- |  | ---------------------------------------------------------------------------------------------------------------------
|Exhibit Number |  | Description                                                                                                          
|31.1           |  | Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a)/15d-14(a)                      
|               | 
|31.2           |  | Certification of the Director of Finance and Treasurer pursuant to Exchange Act Rules 13a-14(a)/15d-14(a)            
|               | 
|32.1           |  | Certification of the Chief Executive Officer and Director of Finance and Treasurer pursuant to 18 U.S.C. Section 1350



3



---

##### Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.



|                       |  |                                                
|---------------------- |  | -----------------------------------------------
|                       |  | AUTOIMMUNE INC.                                
|                       | 
|Date: October 16, 2007 |  | /s/ ROBERT C. BISHOP                           
|                       |  | Robert C. Bishop                               
|                       |  | Chairman, President and Chief Executive Officer
|                       | 
|Date: October 16, 2007 |  | /s/ DIANE M. MCCLINTOCK                        
|                       |  | Diane M. McClintock                            
|                       |  | Director of Finance and Treasurer              



4